Paola Mina-Osorio MD., PhD. has extensive experience in basic research and drug development in Inflammation/Immunology both in academia and in the pharmaceutical industry. She has had prominent roles in several programs in rheumatoid arthritis, psoriatic arthritis, psoriasis and lupus, including small molecule and biologic drug candidates. At the time of this submission she was a Medical Advisor at the Dermatology and Inflammation department at Eli Lilly & Company. She is currently Medical Director, Immunology Medical Affairs at Regeneron Pharmaceuticals, Inc. in Tarrytown, NY, USA .
Paola Mina-Osorio MD., PhD. has extensive experience in basic research and drug development in Inflammation/Immunology both in academia and in the pharmaceutical industry. She has had prominent roles in several programs in rheumatoid arthritis, psoriatic arthritis, psoriasis and lupus, including small molecule and biologic drug candidates. At the time of this submission she was a Medical Advisor at the Dermatology and Inflammation department at Eli Lilly & Company. She is currently Medical Director, Immunology Medical Affairs at Regeneron Pharmaceuticals, Inc. in Tarrytown, NY, USA .